Form 4: Beta Bionics CFO Sells Shares for Tax Obligations

Beta Bionics' Chief Financial Officer, Stephen Feider, sold 1,427 shares of common stock at $29.3359 per share to cover tax withholding obligations.

Summary

• Stephen Feider, Chief Financial Officer of Beta Bionics, Inc. (BBNX), reported a sale of common stock.
• On December 2, 2025, Mr. Feider disposed of 1,427 shares of Beta Bionics common stock.
• The shares were sold at a price of $29.3359 per share.
• The total value of the shares sold is approximately $41,869.99.
• The purpose of the sale was to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Feider directly beneficially owns 42,614 shares of common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine sale of shares to cover tax obligations related to restricted stock unit vesting, which is a neutral event and does not indicate a change in management's confidence or company fundamentals.

Industry Context

This is a routine insider transaction for tax purposes and does not provide specific insights into broader industry trends or competitive landscape.

Stakeholder Impact

• The impact on shareholders is minimal as this is a routine, tax-related sale of a relatively small number of shares by an officer.
• Employees holding restricted stock units may view this as a standard process for managing equity compensation.

Key Dates

Recommendation

This Form 4 reports a routine sale of shares by the CFO to cover tax withholding obligations from restricted stock unit vesting. Such transactions are common and generally do not reflect a change in the company's fundamentals or management's long-term outlook. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Beta Bionics, BBNX, Stephen Feider, CFO, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, Equity Compensation